BusTest Express reports that decentralized clinical trials (DCTs) are revolutionizing patient recruitment by enhancing ...

Expanding clinical trial access locally reduces logistical and financial barriers, making participation feasible for underserved populations. Addressing myths about clinical trials helps patients ...

Alongside physician collaboration, patient advocacy is essential to ensure clinical trials and public policy reflect patient-centered outcomes. In addition to patient-physician collaboration, Debra ...

Digital patient profiles and real-world data enhance oncology trial design, patient recruitment, and reduce trial failure risks. Phesi's platform aligns trial designs with real-world data, minimizing ...

Avik Pal, Founder and CEO of CliniOps, a technology and data company with multiple patents to digitize global clinical trials. When Michael J. Fox and Stephen Hawking publicly shared their personal ...

City of Hope is using generative AI to create operational efficiency, enable patient personalization, improve access to clinical trials and empower breakthrough research. “With the rise of AI, ...

Two innovative, forward-thinking organizations show how rebuilding patient trust is becoming the real breakthrough driving ...

What happens to a patient after I refer them to a clinical trial? Do they leave my practice? Referring patients to a clinical trial is similar to referring them to a specialist. They remain your ...

The field of rare cancer research is rapidly transforming, marked by significant progress in clinical trials and treatment strategies. Rare cancers, as defined by the National Cancer Institute, occur ...

A phase 3 global trial is enrolling previously treated locally advanced/metastatic nonsquamous NSCLC to define DATROWAY efficacy and safety at scale. IDE034 is in open-label phase 1 ...

We have two different buckets of sites. One bucket consists of owned-and-operated Dana-Farber community clinics. The other bucket includes locations which we are affiliated with and have clinical ...